February 1, 2024
Kowa’s hyperlipidemia treatment Parmodia (pemafibrate) again made the biggest impression on GPs through one-on-one detailing by sales reps in December, according to a monthly Intage survey. Intage’s “Impact Track” detailing track survey asks some 4,000 GPs/hospital doctors about the number...read more